Articles

Biomedicine

Protein injection eliminates the symptoms of Duchenne myodystrophy

Perhaps patients with Duchenne myodystrophy will receive a drug capable of maintaining the viability of their muscle tissue, just as insulin supports glucose metabolism in the body of diabetic patients.

28.11.2012

Biomedicine

How to increase the effectiveness of antitumor therapy with oncolytic viruses?

The effectiveness of tumor treatment with oncolytic viruses is reduced due to the activity of the patients' own immune system. The study of these mechanisms will optimize a promising method of antitumor therapy.

28.11.2012

Grants and competitions

Postgraduate study at the Charite Clinic

The German interuniversity cluster NeuroCure, based at the Charite Clinic of the Medical University of Berlin, announces the acceptance of applications for postgraduate studies.

27.11.2012

Exhibitions and conferences

BioNanoMed 2013

The International Congress on Bionanomedicine will be held on March 13-15, 2013 in Krems (Austria).

27.11.2012

Biomedicine

New hope in the treatment of Alzheimer's disease

The new approach, which consists in blocking one of the signaling molecules of the immune system, significantly reduces the severity of changes characteristic of Alzheimer's disease.

27.11.2012

New in Gerontology

Problems with reading in old age

It is easier for young people to read clearer and more contrasting text, and for older people it is more blurred and vague, but old people adapt to these changes by changing the reading technique.

27.11.2012

Grants and competitions

Biologists: Cold Spring Harbor and EMBO courses – 2013

The Dynasty Foundation announces a competition for Russian biologists to participate in practical courses organized in 2013 by the Cold Spring Harbor Laboratory and the European Molecular Biology Organization.

27.11.2012

Biomedicine

Lifelong immunity against all strains of the flu virus?

Thanks to a new method of manufacturing a vaccine based on informational RNA, annual vaccination against influenza may become history in the near future.

26.11.2012

Biomedicine

Telomerase is a potential target of antitumor therapy

The enzyme telomerase is the cause of chronic inflammation in malignant diseases. Reducing its activity with the help of pharmaceuticals can reduce the dosage of traditional chemotherapy drugs.

26.11.2012

New in Gerontology

Aging and sexuality

Age-related decline in sexual activity is characteristic of a person, but it very much depends on the socio-cultural context in which elderly people manifest their sexuality.

26.11.2012

Genetic engineering

Gene therapy against epilepsy

Gene therapy based on a rat model of the disease was used to quickly suppress seizures, prevent their recurrence and for the successful treatment of epileptic foci.

26.11.2012

Cellular technologies

Hybrid bioprinter will improve the quality of artificial cartilage

Cartilage tissues created with the help of a new three-dimensional bioprinter are characterized by higher strength compared to structures obtained by inkjet printing from gel-like material.

26.11.2012

Theories of aging

How does aging begin?

The discoveries made during the yeast experiments bring clarity to the cascade of events that make up the aging process and pave the way to understanding the impact on life expectancy, aging and age-related diseases has the interaction of genetics and environmental factors.

26.11.2012

Biomedicine

Diabetes Medication Helps with Alzheimer's Disease

Rosiglitazone, approved by the FDA for the treatment of insulin resistance in patients with type 2 diabetes, may improve the cognitive function of patients with Alzheimer's disease.

23.11.2012

Prolonging youth

A positive attitude towards aging is good for health

Elderly people who have a positive attitude to aging are more likely to recover from serious illnesses than people with a negative attitude to their age.

23.11.2012

Note to the businessman

Business angels will be helped financially

The RVC Seed Investment Fund announces the launch of the Business Angel program, which involves co-investment on standard terms in early seed stage projects in which business angels invest.

23.11.2012

Various

Flu vaccines are not as effective as we are being told

Modern vaccines protect only 59% of the population aged 18 to 65 from influenza, and for the elderly this figure is much lower. The over-hype of available vaccines keeps scientists from inventing new, much more effective ones.

23.11.2012

Cellular technologies

Improving the efficiency of obtaining iPSCs: proteins – separately, viruses – separately

In addition to inducer proteins, the activation of TLR3, one of the receptors of the innate immune system, is necessary for the effective production of induced pluripotent stem cells from somatic ones.

22.11.2012

Your health

Develop body culture!

Adolescents who had above-average muscle strength at the beginning of the study had a 20-35 percent lower risk of becoming victims of early death as a result of heart disease and in general.

22.11.2012

Genetics

Fertilization with donor sperm: the risk of hereditary diseases will become less

The newly created company GenePeeks will be engaged in the identification of hereditary diseases with a recessive type of inheritance, which can manifest themselves in children conceived as a result of fertilization with donor sperm.

21.11.2012